BRIEF published on 07/24/2024 at 12:35, 2 years 3 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Merger Financing Nasdaq Biopharmaceutical QTORIN™
BRIEF published on 07/24/2024 at 12:35, 2 years 3 months ago Palvella Therapeutics et Pieris Pharmaceuticals annoncent un accord de fusion définitif Financement Nasdaq Biopharmaceutique Fusionnement QTORIN™
PRESS RELEASE published on 07/24/2024 at 12:30, 2 years 3 months ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Palvella Therapeutics, Inc. and Pieris Pharmaceuticals, Inc. announce a merger to focus on rare genetic skin diseases with QTORIN™ rapamycin. Joint webcast on July 24 at 8:30am ET Merger Clinical-stage Genetic Skin Diseases QTORIN™ Rapamycin FDA-approved Therapies
BRIEF published on 04/19/2024 at 18:15, 2 years 6 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Reverse Stock Split Nasdaq Compliance Financial Regulation Pieris Pharmaceuticals Stock Adjustment
BRIEF published on 04/19/2024 at 18:15, 2 years 6 months ago Pieris Pharmaceuticals annonce un regroupement d'actions de 1 pour 80 Réglementation Financière Pieris Pharmaceutique Regroupement D'actions Inversé Conformité NASDAQ Ajustement Des Stocks
PRESS RELEASE published on 04/19/2024 at 18:10, 2 years 6 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Pieris Pharmaceuticals, Inc. announces a 1-for-80 reverse stock split effective on April 22, 2024, to comply with Nasdaq listing requirements. No fractional shares will be issued Reverse Stock Split Compliance Nasdaq Pieris Pharmaceuticals Stockholder Ownership
BRIEF published on 03/27/2024 at 13:05, 2 years 7 months ago Pieris Pharmaceuticals Announces New Strategy to Maximize Financial Potential Shareholder Value Pieris Pharmaceuticals Strategic Reorganization Milestone Payments Royalty Potential
BRIEF published on 03/27/2024 at 13:05, 2 years 7 months ago Pieris Pharmaceuticals annonce une nouvelle stratégie pour maximiser le potentiel financier Valeur Pour Les Actionnaires Pieris Pharmaceutique Réorganisation Stratégique Paiements D'étape Potentiel De Redevances
PRESS RELEASE published on 03/27/2024 at 13:00, 2 years 7 months ago Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential Pieris Pharmaceuticals, Inc. announces strategic repositioning to maximize milestone and royalty potential from immuno-oncology assets. Cost-saving measures extend cash runway into 2027 Strategic Repositioning Cost-saving Measures Pieris Pharmaceuticals Milestone Payments Immuno-oncology Assets
Published on 11/12/2026 at 08:00, 3 hours 15 minutes ago Caledonia Mining Corporation Plc: ABRIDGED AND UNAUDITED QUARTERLY RESULTS AND DETAILS OF MANAGEMENT CONFERENCE CALL for the third quarter and nine months ended September 30, 2026 (the "Quarter" or "Q3 2026" and "Nine Months" respectively)
Published on 11/12/2026 at 01:40, 9 hours 35 minutes ago Nexteer Announces First Share Repurchase Programme of Up to US$60 Million
Published on 11/11/2026 at 23:30, 11 hours 45 minutes ago Faraday Copper Reports Third Quarter 2026 Financial Results and Announces Changes to the Board of Directors
Published on 11/11/2026 at 23:05, 12 hours 10 minutes ago Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 12 hours 15 minutes ago CCL Industries Announces Appointment of New Director
Published on 11/12/2026 at 11:00, 15 minutes ago Final Call: Secure a Fully-Funded PhD at World #18 CUHK Before 1 December
Published on 11/12/2026 at 11:00, 15 minutes ago ABB Ltd: ABB Share buybacks - November 5, 2026 - November 11, 2026
Published on 11/12/2026 at 10:53, 21 minutes ago AUSTRIACARD HOLDINGS AG: DNP’s Voluntary Takeover Offer is unconditionally binding
Published on 11/12/2026 at 10:40, 34 minutes ago Hexnode XDR Adds Threat Intelligence, Alert Prioritization and Automated Remediation
Published on 11/12/2026 at 08:56, 2 hours 18 minutes ago Number of shares and voting rights - October 2026 (In French only)
Published on 11/12/2026 at 08:56, 2 hours 18 minutes ago Nombre total d'actions et droits de vote - octobre 2026
Published on 11/12/2026 at 08:40, 2 hours 35 minutes ago FREY forms a €400 million equity partnership with GIC to invest in premium European retail parks
Published on 11/12/2026 at 08:40, 2 hours 35 minutes ago FREY et GIC s’associent pour investir 400 M€ de capital dans les retail parks premium en Europe
Published on 11/10/2026 at 18:00, 1 day 17 hours ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
